Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Triple Receptor Agonist – RETA activates GLP-1, GIP, and glucagon receptors, making it one of the most advanced investigational peptides available.
Metabolic Support – Preclinical and early clinical research suggests powerful effects on weight management, glucose regulation, and insulin sensitivity.
Convenient Pen Design – Easy-to-use format ensures accurate dosing and reduces preparation steps compared to traditional vials.
High Purity Formula – Manufactured to 99% purity, providing confidence in quality and consistency.
Enhanced Stability – Secure pen design protects peptide integrity for dependable results in laboratory settings.
Investigation into obesity and weight regulation mechanisms
Studies on type 2 diabetes and insulin resistance
Exploration of energy expenditure, lipid metabolism, and appetite regulation
Potential evaluation in metabolic syndrome models
⚠️ Disclaimer: This product is supplied strictly for laboratory research use only. Not for Human Consumption.
Triple Receptor Agonist – RETA activates GLP-1, GIP, and glucagon receptors, making it one of the most advanced investigational peptides available.
Metabolic Support – Preclinical and early clinical research suggests powerful effects on weight management, glucose regulation, and insulin sensitivity.
Convenient Pen Design – Easy-to-use format ensures accurate dosing and reduces preparation steps compared to traditional vials.
High Purity Formula – Manufactured to 99% purity, providing confidence in quality and consistency.
Enhanced Stability – Secure pen design protects peptide integrity for dependable results in laboratory settings.
Investigation into obesity and weight regulation mechanisms
Studies on type 2 diabetes and insulin resistance
Exploration of energy expenditure, lipid metabolism, and appetite regulation
Potential evaluation in metabolic syndrome models
⚠️ Disclaimer: This product is supplied strictly for laboratory research use only. Not for Human Consumption.
